SLC25A25-AS1 expression was significantly elevated in T3 stage PC patients than in T2 stage patients (Figure 2A), and was significantly increased in N1 stage PC patients compared with N0 stage PC patients (Figure 2B). Here, SLC25A25 is linked to pachyonychia congenita.